Literature DB >> 26594557

Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination.

Samira Louhibi1, Imene Belfilali1, Leila Boukli-Hacene1, Thierry Roisnel2.   

Abstract

The crystal structure of the title mol-ecular salt, C5H11N3 (+)·2Cl(-), was redetermined. In comparison with the previous study [Bonnet et al. (1975 ▸). Bull. Soc. Fr. Mineral. Crist. 98, 208-213.], the positions of some H atoms were corrected, allowing a more accurate description of the hydrogen-bonding scheme. In addition, the absolute structure was also determined. The maximum differences in terms of bond lengths and angles between the two determinations are 0.022 Å and 1.43°, respectively. The organic cation display a anti conformation of the protonated amine function and the imidazolium ring. The dihedral angle between the imidazolium plane and the plane through the C-C-N side chain is 29.58 (3)°. In the crystal, the organic cations and Cl(-) anions are stacked alternatively into layers parallel to (100). N-H⋯Cl hydrogen bonds between all H atoms of the ammonium group and both N-H groups of the imidazolium ring and the Cl(-) acceptor anions lead to the linkage of organic and inorganic layers into a three-dimensional network.

Entities:  

Keywords:  crystal structure; histamine; hydrogen bonding; redetermination

Year:  2015        PMID: 26594557      PMCID: PMC4645084          DOI: 10.1107/S2056989015018848

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

Histamine [2-(1H-imidazol-4-yl)ethanamine] is a biogenic amine present in essentially all mammalian tissues and involved in several defense mechanisms of the body. It plays a role in various physiological processes, such as control of gastric acid secretion, neurotransmission, regulation of the microcirculation, and modulation of inflammatory (Cooper et al., 1990 ▸; Barnes, 2001 ▸) and immunological reactions (Schwartz et al., 1991 ▸; Bachert et al., 1998 ▸; Emanuel et al., 1999 ▸). The contribution of histamine in these physiological and pathological processes and the use in pharmacology make it an inter­esting substance in biochemistry (Leurs et al., 1995 ▸; Galoppin & Ponvert, 1997 ▸; O’Mahony et al., 2011 ▸; Jadidi-Niaragh & Mirshafiey, 2010 ▸; Gustiananda et al., 2012 ▸). The structure of the title compound has been determined previously by Bonnet et al. (1975 ▸) who reported lattice parameters of a =7.596 (6), b = 12.706 (8), c = 4.457 (4) Å, β = 91.64 (5)° at room temperature. For the structure of the histamine copper(II) chloride complex and its catalytic activity study, see: Belfilali et al. (2015a ▸), and for the structure of monopronated histamine with Cl− as counter-anion, see: Belfilali et al. (2015b ▸).

Experimental

Crystal data

C5H11N3n class="Chemical">2Cl− M = 184.07 Monoclinic, a = 4.4358 (2) Å b = 12.6281 (4) Å c = 7.5588 (3) Å β = 91.910 (1)° V = 423.18 (3) Å3 Z = 2 Mo Kα radiation μ = 0.70 mm−1 T = 150 K 0.43 × 0.32 × 0.09 mm

Data collection

Bruker APEXII CCD, diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2006 ▸) T min = 0.825, T max = 0.939 3729 measured reflections 1855 independent reflections 1815 reflections with I > 2σ(I) R int = 0.024

Refinement

R[F 2 > 2σ(F 2)] = 0.023 wR(F 2) = 0.058 S = 1.08 1855 reflections 106 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.22 e Å−3 Δρmin = −0.17 e Å−3 Absolute structure: Flack (1983 ▸), 841 Friedel pairs Absolute structure parameter: 0.06 (5)

Data collection: APEX2 (Bruker, 2006 ▸); cell refinement: SAINT (Bruker, 2006 ▸); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999 ▸); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▸); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▸); software used to prepare material for publication: WinGX (Farrugia, 2012 ▸). Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015018848/wm5220sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015018848/wm5220Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015018848/wm5220Isup3.cml Click here for additional data file. . DOI: 10.1107/S2056989015018848/wm5220fig1.tif Tautomeric forms of histamine. Click here for additional data file. . DOI: 10.1107/S2056989015018848/wm5220fig2.tif The mol­ecular structure of the title compound. Displacement ellipsoids are drawn at the 50% probability level. Click here for additional data file. . DOI: 10.1107/S2056989015018848/wm5220fig3.tif Part of the crystal structure with hydrogen bonds shown as dashed lines. CCDC reference: 1051848 Additional supporting information: crystallographic information; 3D view; checkCIF report
C5H11N3+·2ClF(000) = 192
Mr = 184.07Dx = 1.445 Mg m3
Monoclinic, P21Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2ybCell parameters from 2786 reflections
a = 4.4358 (2) Åθ = 2.7–27.5°
b = 12.6281 (4) ŵ = 0.70 mm1
c = 7.5588 (3) ÅT = 150 K
β = 91.910 (1)°Prism, colourless
V = 423.18 (3) Å30.43 × 0.32 × 0.09 mm
Z = 2
Bruker APEXII CCD, diffractometer1815 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.024
CCD rotation images, thin slices scansθmax = 27.5°, θmin = 3.1°
Absorption correction: multi-scan (SADABS; Bruker, 2006)h = −5→5
Tmin = 0.825, Tmax = 0.939k = −16→13
3729 measured reflectionsl = −9→9
1855 independent reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.023H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.058w = 1/[σ2(Fo2) + (0.0327P)2] where P = (Fo2 + 2Fc2)/3
S = 1.08(Δ/σ)max = 0.001
1855 reflectionsΔρmax = 0.22 e Å3
106 parametersΔρmin = −0.17 e Å3
1 restraintAbsolute structure: Flack (1983), 841 Friedel pairs
Primary atom site location: structure-invariant direct methodsAbsolute structure parameter: 0.06 (5)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.9759 (4)0.18301 (13)0.4308 (2)0.0201 (3)
H1A1.115 (6)0.232 (2)0.472 (3)0.05*
H1B0.787 (6)0.217 (2)0.441 (3)0.05*
H1C1.015 (6)0.179 (2)0.316 (4)0.05*
C20.9990 (5)0.07908 (15)0.5236 (2)0.0209 (4)
H2A1.20440.04970.51250.025*
H2B0.8530.02850.4690.025*
C30.9317 (4)0.09457 (15)0.7190 (2)0.0214 (4)
H3A1.0530.15450.76690.026*
H3B0.7160.11270.72990.026*
C41.0019 (4)−0.00243 (13)0.8252 (2)0.0160 (3)
C51.1983 (4)−0.08313 (15)0.8024 (2)0.0189 (3)
H51.3185−0.09450.70250.023*
N61.1904 (3)−0.14577 (12)0.95191 (19)0.0206 (3)
H61.284 (6)−0.206 (2)0.964 (3)0.05*
C70.9952 (4)−0.10582 (15)1.0615 (2)0.0211 (4)
H70.9475−0.13421.17360.025*
N80.8764 (3)−0.01892 (12)0.98803 (17)0.0168 (3)
H80.745 (6)0.021 (2)1.031 (4)0.05*
Cl10.47163 (8)0.32961 (3)0.59693 (5)0.02068 (11)
Cl20.43148 (9)0.15270 (3)0.11930 (5)0.01937 (11)
U11U22U33U12U13U23
N10.0192 (7)0.0233 (9)0.0178 (7)−0.0004 (6)0.0021 (6)0.0025 (6)
C20.0264 (9)0.0187 (9)0.0175 (9)−0.0022 (7)0.0010 (7)−0.0001 (7)
C30.0267 (9)0.0202 (9)0.0174 (8)0.0047 (8)0.0036 (7)0.0012 (7)
C40.0168 (7)0.0158 (8)0.0155 (7)−0.0017 (7)0.0002 (6)−0.0027 (6)
C50.0208 (8)0.0177 (8)0.0183 (8)0.0006 (7)0.0026 (6)−0.0036 (7)
N60.0214 (7)0.0173 (8)0.0233 (7)0.0014 (6)0.0018 (6)0.0014 (6)
C70.0225 (9)0.0215 (9)0.0195 (7)−0.0013 (7)0.0008 (7)0.0033 (7)
N80.0167 (7)0.0168 (7)0.0173 (7)−0.0009 (6)0.0032 (5)−0.0017 (5)
Cl10.01948 (19)0.0235 (2)0.01936 (17)−0.00067 (18)0.00474 (13)−0.00219 (16)
Cl20.01775 (18)0.0187 (2)0.02194 (18)−0.00186 (17)0.00442 (13)−0.00354 (15)
N1—C21.490 (2)C4—C51.355 (3)
N1—H1A0.92 (3)C4—N81.383 (2)
N1—H1B0.95 (3)C5—N61.381 (2)
N1—H1C0.89 (3)C5—H50.95
C2—C31.530 (2)N6—C71.319 (2)
C2—H2A0.99N6—H60.88 (3)
C2—H2B0.99C7—N81.331 (2)
C3—C41.492 (2)C7—H70.95
C3—H3A0.99N8—H80.84 (3)
C3—H3B0.99
C2—N1—H1A113.7 (15)H3A—C3—H3B107.9
C2—N1—H1B113.9 (15)C5—C4—N8106.22 (14)
H1A—N1—H1B105 (2)C5—C4—C3132.25 (16)
C2—N1—H1C112.9 (18)N8—C4—C3121.30 (14)
H1A—N1—H1C103 (2)C4—C5—N6107.03 (15)
H1B—N1—H1C108 (2)C4—C5—H5126.5
N1—C2—C3109.22 (15)N6—C5—H5126.5
N1—C2—H2A109.8C7—N6—C5109.26 (15)
C3—C2—H2A109.8C7—N6—H6126.0 (18)
N1—C2—H2B109.8C5—N6—H6124.3 (17)
C3—C2—H2B109.8N6—C7—N8108.21 (15)
H2A—C2—H2B108.3N6—C7—H7125.9
C4—C3—C2111.78 (14)N8—C7—H7125.9
C4—C3—H3A109.3C7—N8—C4109.27 (14)
C2—C3—H3A109.3C7—N8—H8126.6 (18)
C4—C3—H3B109.3C4—N8—H8124.2 (18)
C2—C3—H3B109.3
N1—C2—C3—C4−170.28 (15)C4—C5—N6—C70.6 (2)
C2—C3—C4—C526.5 (3)C5—N6—C7—N8−0.2 (2)
C2—C3—C4—N8−159.79 (15)N6—C7—N8—C4−0.27 (19)
N8—C4—C5—N6−0.70 (17)C5—C4—N8—C70.61 (17)
C3—C4—C5—N6173.73 (18)C3—C4—N8—C7−174.57 (16)
D—H···AD—HH···AD···AD—H···A
N1—H1A···Cl1i0.92 (3)2.19 (3)3.1071 (17)171 (2)
N1—H1B···Cl10.95 (3)2.34 (3)3.1930 (17)150 (2)
N1—H1C···Cl2i0.89 (3)2.44 (3)3.1768 (16)141 (2)
N6—H6···Cl2ii0.88 (3)2.28 (3)3.1046 (16)157 (2)
N8—H8···Cl2iii0.84 (3)2.28 (3)3.1157 (15)169 (3)
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N1H1ACl1i 0.92(3)2.19(3)3.1071(17)171(2)
N1H1BCl10.95(3)2.34(3)3.1930(17)150(2)
N1H1CCl2i 0.89(3)2.44(3)3.1768(16)141(2)
N6H6Cl2ii 0.88(3)2.28(3)3.1046(16)157(2)
N8H8Cl2iii 0.84(3)2.28(3)3.1157(15)169(3)

Symmetry codes: (i) ; (ii) ; (iii) .

  10 in total

Review 1.  Histamine and serotonin.

Authors:  P J Barnes
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

Review 4.  Molecular pharmacological aspects of histamine receptors.

Authors:  R Leurs; M J Smit; H Timmerman
Journal:  Pharmacol Ther       Date:  1995-06       Impact factor: 12.310

5.  Histamine and the antiallergic antihistamines: a history of their discoveries.

Authors:  M B Emanuel
Journal:  Clin Exp Allergy       Date:  1999-07       Impact factor: 5.018

Review 6.  Regulation of the immune response and inflammation by histamine and histamine receptors.

Authors:  Liam O'Mahony; Mübeccel Akdis; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2011-08-06       Impact factor: 10.793

7.  Sensitive detection of histamine using fluorescently labeled oxido-reductases.

Authors:  Marsia Gustiananda; Alessio Andreoni; Leandro C Tabares; Armand W J W Tepper; Luca Fortunato; Thijs J Aartsma; Gerard W Canters
Journal:  Biosens Bioelectron       Date:  2011-11-15       Impact factor: 10.618

8.  Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.

Authors:  Farhad Jadidi-Niaragh; Abbas Mirshafiey
Journal:  Neuropharmacology       Date:  2010-05-21       Impact factor: 5.250

Review 9.  Histamine--a major role in allergy?

Authors:  C Bachert
Journal:  Clin Exp Allergy       Date:  1998-12       Impact factor: 5.018

10.  Crystal structure of 2-(1H-imidazol-4-yl)ethanaminium chloride.

Authors:  Imene Belfilali; Siham Yebdri; Samira Louhibi; Leila Boukli-Hacene; Thierry Roisnel
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-09
  10 in total
  1 in total

1.  pH-induced conformational changes in histamine in the solid state.

Authors:  Kanchanok Kodchakorn; Piyarat Nimmanpipug; Suttinun Phongtamrug; Kohji Tashiro
Journal:  RSC Adv       Date:  2019-06-20       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.